— Know what they know.
Not Investment Advice

ITGR NYSE

Integer Holdings Corporation
1W: -0.2% 1M: +0.2% 3M: +26.1% YTD: +64.8% 1Y: +71.3% 3Y: +74.3% 5Y: +44.4%
$126.74
+0.22 (+0.17%)
After Hours: $128.27 (+1.53, +1.21%)
Weekly Expected Move ±0.1%
$126 $126 $127 $127 $127
NYSE · Healthcare · Medical - Devices · Tech Score Buy · Power 62 · $4.3B mcap · 29M float · 3.18% daily turnover · Short 39% of daily vol
Credit Risk of going bust: lower than 69% of companies Debt: 24.1% of company value Bonds: $145.3M held by 42 funds → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $2.40 (down 98%), Integer Holdings Corporation would be worth roughly what it owes.
Total debt $1.36B against a stock market value of $4.30B.
Distance to default 7.43 (Merton model): prices to 2026-10-26, balance sheet 2026-07-03, debt counted $627.2M (short-term plus half of long-term), stock volatility 31.6%; Altman Z 2.85. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Smart Money Score
Moderate 50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$4.3B
52W Range62-126.83
Volume827,836
Avg Volume923,309
Beta0.58
Dividend—
Analyst Ratings
8 Buy 8 Hold 0 Sell
Consensus Buy
Company Info
CEOPayman Khales
Employees11,000
SectorHealthcare
IndustryMedical - Devices
IPO Date2000-09-29
5830 Granite Parkway
Plano, TX 75024
US
214 618 5243
About Integer Holdings Corporation

Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.

Recent Insider Trades

NameTypeSharesPriceDate
Khales Payman M-Exempt 2,514 — 2026-10-24
Khales Payman F-InKind 990 $126.54 2026-10-24
Khales Payman M-Exempt 2,514 — 2026-10-24
Tarheel Investors II 0 — 2026-10-05
Tarheel Investors II 836,392 — 2026-10-05

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms